Article · Volume 3, Issue 4 · pp. 336–338
Toxic epidermal necrolysis due to lamotrigine in a pediatric patient
Manish J. Barvaliya1, Mahendra K. Patel1, Tejas K. Patel2, C. B. Tripathi1
- 1Department of Pharmacology, Government Medical College, Bhavnagar.
- 2Department of Pharmacology, GMERS Medical College, Gotri, Vadodara, Gujarat, India Case Report.
Abstract
A 12-year-male child developed toxic epidermal necrolysis (TEN) probably due to lamotrigine. The patient was on antiepileptic therapy (sodium valproate and clonazepam) since 6–7 months, and lamotrigine was added in the regimen 1–2 months back. A serious cutaneous reaction is more likely to occur during the first 2 months of starting lamotrigine. The use of lamotrigine as an add-on to valproate may have precipitated the reaction. Other drugs were ruled out based on the incubation period of TEN. Drug interactions should be kept in mind with multiple antiepileptic therapies. The patient died because of the severity of reactions and delay in starting the treatment with steroids. One must be vigilant in early detection of the reaction.
Keywords: Cutaneous adverse drug reaction; lamotrigine; toxic epidermal necrolysis
The full text of this article is available as a PDF. Open the PDF.
